Dr. Ross M. Moskowitz, MD

Dr. Moskowitz practices at UCI Health - Orange in Orange, California, part of UC Irvine.

Dr. Moskowitz's NPI, 1316262223, was assigned on April 2, 2010. Dr. Moskowitz graduated from UC Irvine School of Medicine in 2008. Dr. Moskowitz holds California license A111351.

Dr. Moskowitz's primary practice is UCI Health - Orange, at 101 City Drive South, Orange, CA 92868 in Orange County. The practice phone is (714) 456-7890.

Dr. Moskowitz's primary practice is UCI Health - Orange in Orange, California, part of UC Irvine. The medical group on file is UCI Health Center for Urological Care.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Moskowitz practices. Vendor and product names are available with a free account.

Urology is Dr. Moskowitz's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Moskowitz is board certified in urology by the American Board of Urology. Dmand AI has Dr. Moskowitz's licenses on file in 2 states: California and Washington.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney disease, kidney stone disease and prostate cancer among the conditions Dr. Moskowitz treats.

CMS data shows 513 Medicare services from Dr. Moskowitz across 6 procedure codes in 2024, for 288 Medicare patients. Medicare paid $42,875 for them.

CMS counts 288 Medicare patients who saw Dr. Moskowitz in 2024. The largest group is 75 to 84, with 131 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 12% are also on Medicaid. Their average risk score is 1.40, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Moskowitz's median patient age at 71, with 8% women.

In 2024, Dr. Moskowitz wrote 1,210 Medicare Part D claims for 219 patients. 84% of them were for generic drugs. CMS names the drug for 1,082 of them, across 12 drugs with 11 or more claims each, at $151,793 in total drug cost. In 2023, CMS named 1,104 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Moskowitz for performance year 2024, reported through an alternative payment model (APM). Dr. Moskowitz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Moskowitz as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Moskowitz, published from 2009 to 2013. 2009 was the busiest year, with 2. The most frequent topics are Laparoscopy and Models, Animal. Dr. Moskowitz has published most often in J Urol. Dr. Moskowitz's most frequent co-authors are Ralph V. Clayman, MD, Geoffrey Neal Box, MD and Adam Geoffrey Kaplan, MD.

CMS Open Payments shows 7 general payments to Dr. Moskowitz from 5 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Calyxo, Inc. paid the most, $226.

Dr. Moskowitz graduated from UC Irvine School of Medicine in 2008. Dr. Moskowitz is a member of AUA.

Dr. Moskowitz is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.